Rega marang bathi mangsa ngarep Supernus Pharmaceuticals, Inc. (SUPN)

Simbol resmi perusahaan supernus.com (SUPN)

Supernus Pharmaceuticals (SUPN) maintains a robust liquidity reserve driven by high margins on its neurological drugs. The company is building a comprehensive ecosystem for CNS disorder therapy, establishing itself as a key partner for physicians. The issuer's forward P/E illustrates the market valuation trend relative to expected earnings, where 7.60 captures the magnitude of this parameter. Growth is constrained by stringent FDA oversight and high patent requirements within the psychiatry sector.

SUPN - Rasio prakiraan rega marang bathi Supernus ing rentang 04.07.2022 - 16.11.2026

Supernus (SUPN) - rincian metrik lan laporan keuangan

Analisis komprehensif perusahaan:SUPN Supernus Corp
Produk mawa merek supernus.com

Forward P/E values share prices relative to projected net income, allowing investors to determine the extent of an asset's overbought status based on future cash flows. By analyzing the forward P/E of Supernus Pharmaceuticals (SUPN), one can confirm the stability of the valuation, as a diversified distribution system for neurological drugs minimizes operational risks and ensures revenue predictability.

Pesaing utama

Pangali Forward P/E BIIB|NBIX - Rasio prakiraan rega marang bathi|Pangali Forward P/E RGC (Regencell Bioscience Ltd)|Kapitalisasi marang proyeksi bathi axsome.com (AXSM)|ACADIA Pharmaceuticals Inc - Pangali Forward P/E|Rasio prakiraan rega marang bathi Xenon Pharmaceuticals Inc.|Viking Therapeutics (VKTX) - Rega marang bathi mangsa ngarep|CPRX (Catalyst Pharmaceuticals) - Rega marang bathi mangsa ngarep|DNLI (denalitherapeutics.com) - Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep HRMY (Harmony Biosciences Holdings, Inc.)|Pangali Forward P/E BHVN|AMLX (Amylyx Pharmaceuticals Inc) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E TRVI (Trevi Pharma)|PRAX (Praxis Corp) - Rasio rega marang bathi sing dikarepake|anavex.com - Pangali Forward P/E|Pangali mangsa ngarep rega marang bathi CBLL (CeriBell, Inc.)|PRTA: Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep ALEC|ANNX (Annexon Biosciences Inc.) - Pangali Forward P/E|omeros.com - Rasio rega marang bathi sing dikarepake|Rega marang bathi mangsa ngarep Neurogene (NGNE)|Kapitalisasi marang proyeksi bathi AC Immune SA|Pangali Forward P/E VYGR (voyagertherapeutics.com)|Pangali Forward P/E Neumora NMRA|Scilex Holding - Pangali Forward P/E|Rasio prakiraan rega marang bathi Tevogen Bio Inc.|Alpha Cognition (ACOG) - Rega marang bathi mangsa ngarep|cogrx.com (CGTX) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Inhibikase Therapeutics|Cassava (SAVA) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Assertio Therapeutics (ASRT)|Kapitalisasi marang proyeksi bathi Coya|Vistagen - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi OVID|Acumen Pharmaceuticals Inc. - Pangali Forward P/E|Rasio prakiraan rega marang bathi CervoMed Inc|ATHE: Pangali Forward P/E|Prakiraan rega marang bathi Clene Nanomedicine|Rega marang bathi mangsa ngarep PepGen Corp|Jupiter Neurosciences (JUNS) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Relmada Therapeutics, Inc. (RLMD)|ANVS - Rasio prakiraan rega marang bathi|gracetx.com - Prakiraan rega marang bathi|AIFF: Rasio rega marang bathi mangsa ngarep|Klotho Neurosciences - Pangali Forward P/E|NRSN (NeuroSense Therapeutics Ltd.) - Rasio rega marang bathi mangsa ngarep|Reviva Pharmaceuticals (RVPH) - Rega marang bathi mangsa ngarep|MTVA (MetaVia Inc.) - Rega marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep NeurAxis, Inc|Rega marang bathi mangsa ngarep HSDT|Pangali Forward P/E PASG|Kapitalisasi marang proyeksi bathi Neuphoria Therapeutics, Inc.|minervaneurosciences.com - Prakiraan rega marang bathi|Pangali Forward P/E Athira ATHA|Addex Therapeutics - Pangali Forward P/E|ALZN - Pangali Forward P/E|Cyclerion (CYCN) - Rega marang bathi mangsa ngarep|Protagenic (PTIX) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Pasithea|Rasio rega marang bathi mangsa ngarep CRGT (Cortigent)|Rega marang bathi mangsa ngarep Avenue Therapeutics (ATXI)|BCLI - Rasio prakiraan rega marang bathi|Pangali Forward P/E CARA (Cara Therapeutics Inc)|CHRO - Prakiraan rega marang bathi|ELYM: Prakiraan rega marang bathi|Kapitalisasi marang proyeksi bathi Intra-Cellular Therapies, Inc. ITCI|Longboard Pharma (LBPH) - Rega marang bathi mangsa ngarep|Marinus - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep NKGen Biotech Inc|NRBO: Pangali mangsa ngarep rega marang bathi|Prakiraan rega marang bathi SAGE (Sage Therapeutics, Inc.)|Kapitalisasi marang proyeksi bathi Neurotrope|Rega marang bathi mangsa ngarep Trevena, Inc. TRVN|Vigil Neuroscience (VIGL) - Rasio prakiraan rega marang bathi|WENA: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi CERE (Cerevel Therapeutics)